Helixate® FS

Control and Prevention of Bleeding Episodes

Helixate® FS is an antihemophilic factor that is indicated for the control and prevention of bleeding episodes in adults and children (0-16 years) with hemophilia A.

Peri-operative Management

Helixate® FS is indicated for surgical prophylaxis in adults and children with hemophilia A.

Routine prophylaxis in Children with Hemophilia A with no Preexisting Joint Damage

Helixate® FS is indicated for routine prophylactic treatment to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no pre-existing joint damage.

*Helixate® FS is not indicated for the treatment of von Willebrand's disease.

For indications, dosing and other information, please refer to the prescribing information.

Helixate® FS ‐ CSL Behring

Size:
250 unit, 2.5 mL vial
NDC #:
00053-8131-02
Download:
PI
Size:
500 unit, 2.5 mL vial
NDC #:
00053-8132-02
Download:
PI
Size:
1000 unit, 2.5 mL vial
NDC #:
00053-8133-02
Download:
PI
Size:
2000 unit, 5 mL vial
NDC #:
00053-8134-02
Download:
PI
Size:
3000 unit, 5 mL vial
NDC #:
00053-8135-02
Download:
PI